Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin(University of Washington), Lalita Ramakrishnan(MRC Laboratory of Molecular Biology), Charles N. Serhan(Harvard University), Sungwhan F. Oh(Brigham and Women's Hospital), Jay C. Vary(University of Washington), Yuxia Zou(Duke Medical Center), Mary‐Claire King(University of Washington), Sarah J. Dunstan(Nuffield Orthopaedic Centre), Ross McFarland(University of Washington), Jeremy Farrar(World Health Organization), Thomas R. Hawn(University of Washington Medical Center), Thad W. Vickery(Brigham and Women's Hospital), Dennis C. Ko(Duke University), Tran Thi Hong Chau(Hospital for Tropical Diseases), Guy Thwaites(University of Oxford), Nguyen Duc Bang(Pham Ngoc Thach Hospital), Francisco J. Roca(University of Washington)
Cited by 572
Related Papers
The global distribution and burden of dengue
|Nature|2013|10.1k
Dengue: a continuing global threat
|Nature Reviews Microbiology|2010|2.1k
Into the Eye of the Cytokine Storm
|Microbiology and Molecular Biology Reviews|2012|2k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Dengue
|New England Journal of Medicine|2012|1.7k